ENVALITH
株式会社ニイタカ logo

NIITAKA Co., Ltd.

4465Standard MarketChemicals

株式会社ニイタカ logo
NIITAKA Co., Ltd.4465
Reference Indicators

Market Cap

136¥100M

P/E (Forecast)

10.3x

P/B

0.8x

Dividend Yield (Forecast)

3.68%

ROE

12.3%

EV/EBITDA

2.4x
Financial Summary
Unit: ¥M
Item
2022May 2022
2023May 2023
2024May 2024
2025May 2025
2026May 2026
Net Sales
17,79219,50422,73923,71424,619
Cost of Sales
10,50012,81814,60315,08015,608
Gross Profit
7,2926,6858,1358,6349,011
SG&A Expenses
5,4665,8306,6596,7096,892
Operating Income
1,8258551,4761,9252,118
Non-operating Income
84889598136
Non-operating Expenses
5456716937
Ordinary Income
1,8558861,5001,9532,217
Extraordinary Income
8512725511
Extraordinary Losses
5539691744
Pre-tax Income
1,8088988112,6042,724
Income Taxes
57733795799824
Net Income
1,2315617051,8051,900
EBITDA
2,4421,4282,0502,4832,674
Gross Margin
41.0%34.3%35.8%36.4%36.6%
Operating Margin
10.3%4.4%6.5%8.1%8.6%
ROA
5.9%2.4%3.1%8.0%8.0%
ROE
10.3%4.4%5.4%12.8%12.3%
Segment Performance
Unit: ¥M
2025
SegmentNet SalesOperating IncomeOperating Margin
ケミカル事業22,2281,6477.4%
ヘルスケア事業1,48627718.6%